Cargando…

2735. Treatment patterns and clinical outcomes of acyclovir resistant and refractory human herpes simplex virus infection after allogeneic hematopoietic cell transplantation

BACKGROUND: Treatment options for mucocutaneous herpes simplex virus infections (HSV) refractory or resistant (r/r) to acyclovir (ACV) are limited. High-dose ACV continuous infusion, foscarnet (FCN), cidofovir (CDV), and/or topical agents have been used. We report treatment patterns and outcomes of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Yeon Joo, Li, Yuxuan, Han, Gyuri, Shah, Gunjan, Tamari, Roni, Perales, Miguel, Papanicolaou, Genovefa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677066/ http://dx.doi.org/10.1093/ofid/ofad500.2346

Ejemplares similares

1563. Relationship of Cumulative Viral Burden of Adenovirus with Mortality in Allogeneic Hematopoietic Cell Transplant Recipients with Early Adenovirus Viremia
por: Lee, Yeon Joo, et al.
Publicado: (2018)

1104. Risk Factors and Outcomes of Refractory and/or Resistant Cytomegalovirus (CMV) Infection after Allogeneic Hematopoietic Stem Cell Transplantation
por: Karantoni, Eleni, et al.
Publicado: (2020)

1760. Outcomes of Acyclovir-Resistant Herpes Simplex Virus Infections in Hematologic Malignancies and Hematopoietic Cell Transplant
por: Ross, Justine Abella, et al.
Publicado: (2019)

Alopecia Following Oral Acyclovir for the Treatment of Herpes Simplex Keratitis
por: Sharma, Ashok, et al.
Publicado: (2014)

Neonatal Herpes Simplex Fulminant Hepatitis Successfully Treated with Acyclovir
por: Abuhasna, Said D., et al.
Publicado: (2012)

Necrotizing Keratitis Caused by Acyclovir-Resistant Herpes Simplex Virus
por: Toriyama, Koji, et al.
Publicado: (2014)

Treatment of acyclovir-resistant herpes simplex virus with intralesional cidofovir
por: Enescu, Christina D., et al.
Publicado: (2021)

Acyclovir for ventilator-associated pneumonia refractory to antibiotics and with high viral herpes simplex load: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020)

Prevalence of Intrathecal Acyclovir Resistant Virus in Herpes Simplex Encephalitis Patients
por: Mitterreiter, Johanna G., et al.
Publicado: (2016)

Herpes Simplex Encephalitis Complicated by Cerebral Hemorrhage during Acyclovir Therapy
por: Harada, Yukinori, et al.
Publicado: (2017)

A Rare Case of Congenital Herpes Simplex Virus Infection with Therapeutic Response to Acyclovir
por: Jangid, Neha C., et al.
Publicado: (2023)

Thrombocytopenia Secondary to Herpes Simplex Virus-2 Infection Successfully Treated by Acyclovir
por: Siddiqui, Raheel S, et al.
Publicado: (2020)

Hypertrophic herpes simplex virus 2 infection resistant to acyclovir in an immunosuppressed patient
por: Tan, Charlie, et al.
Publicado: (2023)

1291. Safety of Isavuconazole Compared with Voriconazole as Primary Antifungal Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients
por: Bogler, Yael, et al.
Publicado: (2020)

Utilization of nanotechnology to enhance percutaneous absorption of acyclovir in the treatment of herpes simplex viral infections
por: Al-Subaie, Mutlaq M, et al.
Publicado: (2015)

Acyclovir resistance in herpes simplex virus type I encephalitis: a case report
por: Bergmann, M., et al.
Publicado: (2016)

Clinical efficacy of oral and topical acyclovir in herpes simplex virus stromal necrotizing keratitis
por: Dutt, Surabhi, et al.
Publicado: (2016)

Omeprazole Increases the Efficacy of Acyclovir Against Herpes Simplex Virus Type 1 and 2
por: Michaelis, Martin, et al.
Publicado: (2019)

Isolation, characterization and acyclovir susceptibility of herpes simplex virus isolates among immunocompromised patients
por: Nag, Soumyabrata, et al.
Publicado: (2021)

Presumed herpes simplex virus ulcerative nodular episcleritis treated by topical acyclovir alone
por: Hoshing, Abhishek, et al.
Publicado: (2022)

Real-World Experience of Voriconazole Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients: A Single-Center Study
por: Chan, Shuk-Ying, et al.
Publicado: (2017)

595. Letermovir (LTV) for Secondary Cytomegalovirus (CMV) Prevention in High Risk Hematopoietic Cell Transplant (HCT) Recipients: Interim Results of a Single Center, Open Label Study
por: Han, Gyuri, et al.
Publicado: (2021)

Implementation of In-house PCR Testing for Herpes Simplex Virus Encephalitis: Impact on Patient Acyclovir Exposure
por: Beaulieu, Ronald, et al.
Publicado: (2017)

Herpes simplex virus infection, Acyclovir and IVIG treatment all independently cause gut dysbiosis
por: Ramakrishna, Chandran, et al.
Publicado: (2020)

Cutaneous Legionella infections in allogeneic hematopoietic cell transplantation recipients
por: Vaidya, Toral, et al.
Publicado: (2020)

1557. Acyclovir-Resistant (ACV-R) Herpes Simplex Virus (HSV) Disease in Patients with Hematologic Malignancies (HM) and Hematopoietic-Cell Transplant (HCT) Recipients
por: Pandit, Alisha, et al.
Publicado: (2018)

Preparation and Evaluation of Novel In Situ Gels Containing Acyclovir for the Treatment of Oral Herpes Simplex Virus Infections
por: Chaudhary, Binu, et al.
Publicado: (2014)

Empirical treatment with parenteral acyclovir in a child with herpes simplex virus hepatitis and acute lymphoblastic leukemia
por: Faqih, Nesreen A., et al.
Publicado: (2018)

Efficacy of acyclovir for herpes simplex encephalitis: A protocol for a systematic review of randomized controlled trial
por: Wang, Wei, et al.
Publicado: (2019)

BK Polyoma Virus Nephropathy in Hematopoietic Cell Transplant Recipients with Renal Dysfunction
por: Lee, Yeon Joo, et al.
Publicado: (2017)

Inactivation of acyclovir-sensitive and -resistant strains of herpes simplex virus type 1 in vitro by photodynamic antimicrobial chemotherapy
por: Latief, Miftahul Akhyar, et al.
Publicado: (2015)

The inhibitory effect of Acyclovir loaded nano-niosomes against herpes simplex virus type-1 in cell culture
por: Monavari, Seyed Hamidreza, et al.
Publicado: (2014)

Synergistic effects of acyclovir and 3, 19- isopropylideneandrographolide on herpes simplex virus wild types and drug-resistant strains
por: Priengprom, Thongkoon, et al.
Publicado: (2015)

Impact of acyclovir use on survival of patients with ventilator-associated pneumonia and high load herpes simplex virus replication
por: Schuierer, Lukas, et al.
Publicado: (2020)

Role of Intravenous Acyclovir in Treatment of Herpes Simplex Virus Stromal Keratitis with Ulceration: A Review of 2 Cases
por: Pisitpayat, Punyanuch, et al.
Publicado: (2021)

Non-cytopathic herpes simplex virus type-1 isolated from acyclovir-treated patients with recurrent infections
por: Roy, Subrata, et al.
Publicado: (2022)

1060. Pritelivir in Immunocompromised Patients with Mucocutaneous Acyclovir-Resistant Herpes Simplex Virus-Infections – First Case Series
por: Albrecht, Kim WorkowskiJoerg, et al.
Publicado: (2021)

609. Acute Kidney Injury During Treatment with Intravenous Acyclovir (AKITA) for Suspected Neonatal Herpes Simplex Virus Infection
por: Haltzman, Brittany L, et al.
Publicado: (2018)

Association between sensitivity of viral thymidine kinase-associated acyclovir-resistant herpes simplex virus type 1 and virulence
por: Omura, Natsumi, et al.
Publicado: (2017)

Discovery, Chemistry, and Preclinical Development of Pritelivir, a Novel Treatment Option for Acyclovir-Resistant Herpes Simplex Virus Infections
por: Birkmann, Alexander, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3kse3bu2a0p5uo4ovc6ojamor5